Granules India plans seven new launches in regulated markets

Pharma company Granules India is planning seven new launches in the regulated markets. These new products are expected to serve as key drivers for growth over the next four quarters.

Highlighting the scope of this expansion, Priyanka Chigurupati, Executive Director of Granules Pharmaceuticals, said these are essentially for the US Europe, Canada, and the UK. "These are the launches that we will start in Q3, and Q4, the full effect of which will fill in FY25. So that is essentially the growth drivers for the next four quarters.”

Chigurupati mentioned a likely improvement in existing margins for the rest of the year, with a more substantial impact anticipated in the subsequent quarters as production backlogs are addressed and new launches are executed.